logo

For the Inventor, By the Inventor

CA

Labopharm Inc.


USPTO Granted Patents = 16



Trademarks = 1

Forward Citations = 408

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Jean-Christophe Leroux (7 out of 25 patents)

silverMedal Maxime Ranger (5 out of 7 patents)

bronzeMedal Mircea Alexandru Mateescu (4 out of 7 patents)

4.  Vincent Lenaerts (3 out of 3 patents)

5.  Yves Dumoulin (3 out of 3 patents)

6.  Sonia Gervais (2 out of 18 patents)

7.  David Lessard (2 out of 4 patents)

8.  Sandra Gori (2 out of 3 patents)

9.  Laibin Luo (2 out of 3 patents)

10.  Damon Smith (2 out of 21 patents)

11.  Miloud Rahmouni (2 out of 12 patents)

12.  Vincent Lenaerts (2 out of 5 patents)

13.  Yuan Wang (2 out of 2 patents)

14.  Julie Lafreniere (2 out of 2 patents)

15.  Jean-Francois Meunier (2 out of 2 patents)


16 patents:

1. 7988998 - Sustained-release tramadol formulations with 24-hour efficacy (2011-08-02),
2. 7838600 - Process for the preparation of amphiphilic poly(N-vinyl-2-pyrrolidone) block copolymers (2010-11-23),
3. 7829120 - Trazodone composition for once a day administration (2010-11-09),
4. 7510731 - Water-soluble stabilized self-assembled polyelectrolytes (2009-03-31),
5. 7262253 - Process for the preparation of amphiphilic poly (N-vinyl-2-pyrrolidone) block copolymers (2007-08-28),
6. 7094810 - pH-sensitive block copolymers for pharmaceutical compositions (2006-08-22),
7. 7018655 - Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions (2006-03-28),
8. 6939564 - Water-soluble stabilized self-assembled polyelectrolytes (2005-09-06),
9. 6780428 - Unimolecular polymeric micelles with an ionizable inner core (2004-08-24),
10. 6780324 - Preparation of sterile stabilized nanodispersions (2004-08-24),
11. 6419957 - Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents (2002-07-16),
12. 6338859 - Polymeric micelle compositions (2002-01-15),
13. 5885615 - Pharmaceutical controlled release tablets containing a carrier made of (1999-03-23),
14. 5616343 - Cross-linked amylose as a binder/disintegrant in tablets (1997-04-01),
15. 5603956 - Cross-linked enzymatically controlled drug release (1997-02-18),
Labopharm Inc. is a pharmaceutical company that specializes in the development and commercialization of innovative drugs. With a focus on improving patient outcomes, Labopharm Inc. harnesses its expertise in drug delivery technologies to enhance the effectiveness and convenience of medications. By leveraging research and development capabilities, Labopharm Inc. aims to address unmet medical needs and provide patients with safer and more effective treatment options.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#106 in

#891 in Canada

#36,684 in the World

...
CA

Labopharm Inc.

Forward Citations = 408

35 inventors:

goldMedal Jean-Christophe Leroux (7 out of 25 patents)

silverMedal Maxime Ranger (5 out of 7 patents)

bronzeMedal Mircea Alexandru Mateescu (4 out of 7 patents)

4.  Vincent Lenaerts (3 out of 3 patents)

5.  Yves Dumoulin (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…